Med Ed 101

JUNE 22, 2025

Nonsteroidal anti-inflammatory drugs (NSAIDs) are routinely used for pain and inflammation, but they are also commonly implicated in clinically significant interactions. As medication experts, pharmacists play a critical role in recognizing and navigating these risks. Below are five of the most important NSAID drug interactions that pharmacists should watch for in daily practice.

Express Pharma

JUNE 22, 2025

Eli Lilly and Company has announced detailed findings from its Phase 3 clinical trials—QWINT-1, QWINT-3, and QWINT-4—assessing the safety and efficacy of once-weekly investigational insulin efsitora alfa (efsitora) in adults with type 2 diabetes. The results were shared during the American Diabetes Association (ADA) 85th Scientific Sessions 2025. Simultaneously, data from QWINT-1 was published in The New England Journal of Medicine, while QWINT-3 and QWINT-4 findings were published in The Lance

Diabetes

Pharmacy Times

JUNE 22, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

Pharmacy Technician

Pharmaceutical Technology

JUNE 22, 2025

David W Miller, CEO of Genesis Research Group, discusses how pharma's decade-long development approach is no longer fit for purpose.

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

Pharmacy Times

JUNE 22, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

Pharmacy Technician

Pharmacy Joe

JUNE 22, 2025

In this episode, I’ll discuss whether there is an association between the sedative dose and postintubation hypotension and rapid sequence intubation. Episode 1037: Hypotension After Intubation - Is It the Sedative Dose That Matters? Subscribe on iTunes , Android , or Stitcher When a patient who requires sedation for intubation also has hemodynamic instability, a common recommendation is to lower the dose of sedative given in hopes of preventing further hemodynamic compromise.

Inpatient

STAT

JUNE 22, 2025

CHICAGO — Late-stage results of Novo Nordisk’s obesity candidate CagriSema suggest the drug is comparable to Eli Lilly’s Zepbound on safety and efficacy, further data indicating that CagriSema may not be the standout treatment that investors had hoped for. Novo previously reported that patients on CagriSema lost 20% of their weight in a 68-week Phase 3 trial when looking at all participants, a similar level of weight loss seen in Zepbound studies.

Drug Development

Pharmacy Times

JUNE 22, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

Pharmacy Technician

RX Note

JUNE 22, 2025

Introduction Modern web app development typically involves three core phases: Code development and version control Application hosting and deployment Domain name registration and DNS configuration Code Development and Version Control The foundation of any application is its code. Developers typically begin by setting up a local development environment using tools like Visual Studio Code.

Pharmacy Times

JUNE 22, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

Diabetes

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

RX Note

JUNE 22, 2025

Introduction Modern web app development typically involves three core phases: Code development and version control Application hosting and deployment Domain name registration and DNS configuration Code Development and Version Control The foundation of any application is its code. Developers typically begin by setting up a local development environment using tools like Visual Studio Code.

FDA Law Blog: Biosimilars

JUNE 22, 2025

By JP Ellison — Last Friday, the Supreme Court delivered a trio of decisions making it easier to litigate against the federal government. The facts and law in each case matter, and as is often the case when the Supreme Court “decides” an issue, much remains to be seen. That said, it’s hard to see how the score on Friday wasn’t 3 for regulated industry and 0 for the federal government.